Client: Novotech
Engaged: 1996
Partner Agency: DMG

Challenge:
In 1996, Novotech was a small, emerging full-service clinical research organization (CRO) with fewer than 10 team members and limited market visibility. The challenge was to position the company as a credible leader in the highly competitive clinical research space and help grow the Australian company to an Asia Pacific firm, then to a global enterprise.

Solution:
DMG partnered with Novotech as their full-service communications agency, managing all media relations, industry awards, keynote placements, and global conference strategies. Over 25 years, DMG delivered a consistent narrative of innovation and leadership, securing high-impact media coverage and establishing Novotech’s executives as global industry thought leaders.

Outcome:
Novotech recently achieved a market valuation of $4 billion and investments of more than $3 billion, with DMG’s strategic media communications support recognized as playing a lead role in building brand credibility, investor interest, and market leadership.

Novotech has grown from a local startup into a globally recognized CRO, with 30 offices across multiple regions and over 3,000 employees. Novotech, now headquartered in Singapore, is one of the world’s leading full-service clinical CROs, providing biotech and small- to mid-sized pharmaceutical companies with an accelerated path to market. Today, the company has a global footprint across the Asia-Pacific region, North America, and Europe, and partnerships with more than 5,000 trial sites. Novotech has a leading position in the most innovative areas of clinical research such as cell and gene therapies, radiopharmaceuticals and mRNA trials.